Found 6 matching trials
VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection PHASE2 This is a clinical study to investigate the safety, tolerability and immuno...
Show More Location
General Practitioners Research Institute (GPRI)
Learn More & Join Trial
Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects PHASE1 A multicenter, 3-arm randomized dose finding study in the UK to evaluate sa...
Show More Location
Queen Elizabeth Hospital
Learn More & Join Trial
COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222 PHASE3 This is a multicentre, randomized, observer-blind, active-controlled, super...
Show More Location
Barnsley Hospital NHS FT
Learn More & Join Trial
Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years PHASE3 This is a A Phase III, Open label, Multicenter, Single Arm Study to assess ...
Show More Location
Southern Clinical Trials Waitemata
Learn More & Join Trial
Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination PHASE3 Data from some studies indicate the decline in the effectiveness of the aut...
Show More Location
Centro de Estudios en Infectología Pediátrica
Learn More & Join Trial
COVID-19 Paediatric VLA2001-321 Study PHASE2 This is a Randomized, Double-blinded, Active-controlled Study to evaluate t...
Show More Location
Multiple Locations
Learn More & Join Trial